Previous Article | Next Article 
Infection and Immunity, October 2002, p. 5547-5555, Vol. 70, No. 10
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.10.5547-5555.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Genetic Immunization Elicits Antigen-Specific Protective Immune Responses and Decreases Disease Severity in Trypanosoma cruzi Infection
Nisha Garg
and Rick L. Tarleton*
Center for Tropical and Emerging Infectious Diseases and Department of Cellular Biology, University of Georgia, Athens, Georgia 30602
Received 13 February 2002/
Returned for modification 12 April 2002/
Accepted 12 July 2002
Immunity to Trypanosoma cruzi requires elicitation of humoral and cell-mediated immune responses to extracellular trypomastigotes and intracellular amastigotes. In this study, the effectiveness of the T. cruzi trans-sialidase family (ts) genes ASP-1, ASP-2, and TSA-1 as genetic vaccines was assessed. Immunization of mice with plasmids encoding ASP-1, ASP-2, or TSA-1 elicited poor antigen-specific cytotoxic-T-lymphocyte (CTL) activity and T. cruzi-specific antibody responses. Codelivery of interleukin-12 and granulocyte-macrophage colony-stimulating factor plasmids with antigen-encoding plasmids resulted in a substantial increase in CTL activity and antibody production and in increased resistance to T. cruzi infection. In pooled results from two to four experiments, 30 to 60% of mice immunized with antigen-encoding plasmids and 60 to 80% of mice immunized with antigen-encoding plasmids plus cytokine adjuvants survived a lethal challenge with T. cruzi. In comparison, 90% of control mice injected with empty plasmid DNA died during the acute phase of infection. However, the pool of three ts genes provided no greater protection than the most effective single gene (ASP-2) either with or without coadministration of cytokine plasmids. Importantly, the extent of tissue parasitism, inflammation, and associated tissue damage in skeletal muscles during the chronic phase of T. cruzi infection in mice immunized with antigen-encoding plasmids plus cytokine adjuvants was remarkably reduced compared to mice immunized with only cytokine adjuvants or empty plasmid DNA. These results identify new vaccine candidates and establish some of the methodologies that might be needed to develop effective vaccine-mediated control of T. cruzi infection. In addition, this work provides the first evidence that prophylactic genetic immunization can prevent the development of Chagas disease.
* Corresponding author. Mailing address: Department of Cellular Biology, University of Georgia, Athens, GA 30602. Phone: (706) 542-3362. Fax: (706) 542-4271. E-mail:
tarleton{at}cb.uga.edu.
Editor: J. M. Mansfield
Present address: Departments of Microbiology and Immunology and Pathology, University of Texas Medical Branch, Galveston, TX 77555.
Infection and Immunity, October 2002, p. 5547-5555, Vol. 70, No. 10
0019-9567/02/$04.00+0 DOI: 10.1128/IAI.70.10.5547-5555.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
de Alencar, B. C. G., Persechini, P. M., Haolla, F. A., de Oliveira, G., Silverio, J. C., Lannes-Vieira, J., Machado, A. V., Gazzinelli, R. T., Bruna-Romero, O., Rodrigues, M. M.
(2009). Perforin and Gamma Interferon Expression Are Required for CD4+ and CD8+ T-Cell-Dependent Protective Immunity against a Human Parasite, Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost Vaccination. Infect. Immun.
77: 4383-4395
[Abstract]
[Full Text]
-
Bhatia, V., Garg, N. J.
(2008). Previously Unrecognized Vaccine Candidates Control Trypanosoma cruzi Infection and Immunopathology in Mice. CVI
15: 1158-1164
[Abstract]
[Full Text]
-
Silveira, E. L. V., Claser, C., Haolla, F. A. B., Zanella, L. G., Rodrigues, M. M.
(2008). Novel Protective Antigens Expressed by Trypanosoma cruzi Amastigotes Provide Immunity to Mice Highly Susceptible to Chagas' Disease. CVI
15: 1292-1300
[Abstract]
[Full Text]
-
Cazorla, S. I., Becker, P. D., Frank, F. M., Ebensen, T., Sartori, M. J., Corral, R. S., Malchiodi, E. L., Guzman, C. A.
(2008). Oral Vaccination with Salmonella enterica as a Cruzipain-DNA Delivery System Confers Protective Immunity against Trypanosoma cruzi. Infect. Immun.
76: 324-333
[Abstract]
[Full Text]
-
Hoft, D. F., Eickhoff, C. S., Giddings, O. K., Vasconcelos, J. R. C., Rodrigues, M. M.
(2007). Trans-Sialidase Recombinant Protein Mixed with CpG Motif-Containing Oligodeoxynucleotide Induces Protective Mucosal and Systemic Trypanosoma cruzi Immunity Involving CD8+ CTL and B Cell-Mediated Cross-Priming. J. Immunol.
179: 6889-6900
[Abstract]
[Full Text]
-
Duthie, M. S., Kahn, M., Zakayan, A., White, M., Kahn, S. J.
(2007). Parasite-Induced Chronic Inflammation Is Not Exacerbated by Immunotherapy before or during Trypanosoma cruzi Infection. CVI
14: 1005-1012
[Abstract]
[Full Text]
-
Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., Simoes, M. V.
(2007). Pathogenesis of Chronic Chagas Heart Disease. Circulation
115: 1109-1123
[Abstract]
[Full Text]
-
Wen, J.-J., Bhatia, V., Popov, V. L., Garg, N. J.
(2006). Phenyl-{alpha}-tert-Butyl Nitrone Reverses Mitochondrial Decay in Acute Chagas' Disease. Am. J. Pathol.
169: 1953-1964
[Abstract]
[Full Text]
-
Giddings, O. K., Eickhoff, C. S., Smith, T. J., Bryant, L. A., Hoft, D. F.
(2006). Anatomical Route of Invasion and Protective Mucosal Immunity in Trypanosoma cruzi Conjunctival Infection.. Infect. Immun.
74: 5549-5560
[Abstract]
[Full Text]
-
Tzelepis, F., de Alencar, B. C. G., Penido, M. L. O., Gazzinelli, R. T., Persechini, P. M., Rodrigues, M. M.
(2006). Distinct Kinetics of Effector CD8+ Cytotoxic T Cells after Infection with Trypanosoma cruzi in Naive or Vaccinated Mice. Infect. Immun.
74: 2477-2481
[Abstract]
[Full Text]
-
Araujo, A. F. S., de Alencar, B. C. G., Vasconcelos, J. R. C., Hiyane, M. I., Marinho, C. R. F., Penido, M. L. O., Boscardin, S. B., Hoft, D. F., Gazzinelli, R. T., Rodrigues, M. M.
(2005). CD8+-T-Cell-Dependent Control of Trypanosoma cruzi Infection in a Highly Susceptible Mouse Strain after Immunization with Recombinant Proteins Based on Amastigote Surface Protein 2. Infect. Immun.
73: 6017-6025
[Abstract]
[Full Text]
-
Kerepesi, L. A., Keiser, P. B., Nolan, T. J., Schad, G. A., Abraham, D., Nutman, T. B.
(2005). DNA Immunization with Na+-K+ATPase (Sseat-6) Induces Protective Immunity to Larval Strongyloides stercoralis in Mice. Infect. Immun.
73: 2298-2305
[Abstract]
[Full Text]
-
Bhatia, V., Sinha, M., Luxon, B., Garg, N.
(2004). Utility of the Trypanosoma cruzi Sequence Database for Identification of Potential Vaccine Candidates by In Silico and In Vitro Screening. Infect. Immun.
72: 6245-6254
[Abstract]
[Full Text]
-
Dumonteil, E., Escobedo-Ortegon, J., Reyes-Rodriguez, N., Arjona-Torres, A., Ramirez-Sierra, M. J.
(2004). Immunotherapy of Trypanosoma cruzi Infection with DNA Vaccines in Mice. Infect. Immun.
72: 46-53
[Abstract]
[Full Text]
-
Michailowsky, V., Luhrs, K., Rocha, M. O. C., Fouts, D., Gazzinelli, R. T., Manning, J. E.
(2003). Humoral and Cellular Immune Responses to Trypanosoma cruzi-Derived Paraflagellar Rod Proteins in Patients with Chagas' Disease. Infect. Immun.
71: 3165-3171
[Abstract]
[Full Text]
-
Boscardin, S. B., Kinoshita, S. S., Fujimura, A. E., Rodrigues, M. M.
(2003). Immunization with cDNA Expressed by Amastigotes of Trypanosoma cruzi Elicits Protective Immune Response against Experimental Infection. Infect. Immun.
71: 2744-2757
[Abstract]
[Full Text]